{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:01:55Z","timestamp":1789786915948,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100025792","name":"Kaleidoscope of Hope Ovarian Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009930","name":"Navicent Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>For decades, ovarian cancer (OC) therapy has mainly relied on a regimen of tumor resection followed by treatment with cisplatin and paclitaxel. While this treatment is usually effective initially, resistance to this regimen in OC is widespread and is often the cause of death in OC patients. In the attempt to find new molecular targets for the treatment of chemoresistant OC, understanding the precise mechanisms of chemoresistance remains a paramount task. This review examines the critical roles of the lysosome in the instigation of chemoresistance in OC and explores possible clinical applications for overcoming chemoresistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Lysosomes contribute to chemoresistance through various mechanisms, including increased lysosomal biogenesis, resulting from the enhanced activity of transcription factor EB, a master regulator of the autophagy-lysosome pathway, which enhances cellular capacity for drug sequestration. Lysosomal exocytosis allows the cell to secrete chemotherapeutic agents from OC cells. Lysosomal autophagy pathways enable OC cells to selectively recycle cell components during chemotherapeutic stress. Finally, lysosomal signaling pathways disrupt various cell death mechanisms such as apoptosis, necroptosis, and ferroptosis, which allow cancer cells to evade death under chemotherapeutic stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Targeting lysosomal biogenesis, stage-specific autophagy modulation, and lysosome-dependent metabolic vulnerabilities are promising avenues for sensitization of chemoresistant OC cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11912-026-01742-1","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:54:58Z","timestamp":1770306898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lys-ing the Resistance: Targeting Lysosomes to Overcome Chemoresistance in Ovarian Cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Aditya","family":"Vayalapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balint","family":"Kacsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Chefetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1742_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2023.100204","volume":"78","author":"B Gutic","year":"2023","unstructured":"Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Dugalic MG, et al. Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian Oncology Centre. Clinics. 2023;78:100204. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100204.","journal-title":"Clinics"},{"key":"1742_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287\u201399. https:\/\/doi.org\/10.2147\/IJWH.S197604.","journal-title":"Int J Womens Health"},{"key":"1742_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104434","volume":"201","author":"I Miras","year":"2024","unstructured":"Miras I, Est\u00e9vez-Garc\u00eda P, Mu\u00f1oz-Galv\u00e1n S. Clinical and molecular features of platinum resistance in ovarian cancer. Crit Rev Oncol Hematol. 2024;201:104434. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104434.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl8","key":"1742_CR4","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","volume":"28","author":"EL Christie","year":"2017","unstructured":"Christie EL, Bowtell DDL. Acquired chemotherapy resistance in ovarian cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2017;28(suppl8):viii13\u20135. https:\/\/doi.org\/10.1093\/annonc\/mdx446.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"1","key":"1742_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.20517\/cdr.2021.122","volume":"5","author":"L Cuesta-Casanovas","year":"2022","unstructured":"Cuesta-Casanovas L, Delgado-Mart\u00ednez J, Cornet-Masana JM, Carb\u00f3 JM, Cl\u00e9ment-Demange L, Risue\u00f1o RM. Lysosome-mediated chemoresistance in acute myeloid leukemia. Cancer Drug Resist (Alhambra Calif). 2022;5(1):233\u201344. https:\/\/doi.org\/10.20517\/cdr.2021.122.","journal-title":"Cancer Drug Resist (Alhambra Calif)"},{"issue":"11","key":"1742_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol. 2024;25(11):926\u201346. https:\/\/doi.org\/10.1038\/s41580-024-00757-5.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"1742_CR7","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1111\/febs.16820","volume":"291","author":"J Xu","year":"2024","unstructured":"Xu J, Gu J, Pei W, Zhang Y, Wang L, Gao J. The role of lysosomal membrane proteins in autophagy and related diseases. FEBS J. 2024;291(17):3762\u201385. https:\/\/doi.org\/10.1111\/febs.16820.","journal-title":"FEBS J"},{"issue":"5","key":"1742_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/10985549.2025.2494762","volume":"45","author":"R Zhang","year":"2025","unstructured":"Zhang R, Vooijs MA, Keulers TG. Key mechanisms in lysosome stability, degradation and repair. Mol Cell Biol. 2025;45(5):212\u201324. https:\/\/doi.org\/10.1080\/10985549.2025.2494762.","journal-title":"Mol Cell Biol"},{"issue":"6036","key":"1742_CR9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u201333. https:\/\/doi.org\/10.1126\/science.1204592.","journal-title":"Science"},{"issue":"1","key":"1742_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01507-y","volume":"22","author":"S Gagliardi","year":"2024","unstructured":"Gagliardi S, Mitruccio M, Di Corato R, Romano R, Aloisi A, Rinaldi R, et al. Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells. Cell Communication and Signaling\u202f: CCS. 2024a;22(1):165. https:\/\/doi.org\/10.1186\/s12964-024-01507-y.","journal-title":"Cell Communication and Signaling : CCS"},{"key":"1742_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020219","author":"R Petruzzelli","year":"2022","unstructured":"Petruzzelli R, Mariniello M, De Cegli R, Catalano F, Guida F, Di Schiavi E, et al. TFEB regulates ATP7B expression to promote platinum chemoresistance in human ovarian cancer cells. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11020219.","journal-title":"Cells"},{"key":"1742_CR12","doi-asserted-by":"crossref","unstructured":"Sengupta S, Datta M, Datta S. (2023). Beta-Glucosidase: Structure, function, and industrial applications. In Glycoside Hydrolases (pp. 97\u2013120).","DOI":"10.1016\/B978-0-323-91805-3.00004-6"},{"issue":"1","key":"1742_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4196\/kjpp.2023.27.1.21","volume":"27","author":"G Wang","year":"2023","unstructured":"Wang G, Ouyang B, Jing F, Dai X. GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways. Korean J Physiol Pharmacol. 2023a;27(1):21\u20139. https:\/\/doi.org\/10.4196\/kjpp.2023.27.1.21.","journal-title":"Korean J Physiol Pharmacol"},{"key":"1742_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.biopha.2017.04.113","volume":"91","author":"X Zhou","year":"2017","unstructured":"Zhou X, Huang Z, Yang H, Jiang Y, Wei W, Li Q, et al. \u03b2-Glucosidase inhibition sensitizes breast cancer to chemotherapy. Biomed Pharmacother. 2017;91:504\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.113.","journal-title":"Biomed Pharmacother"},{"issue":"9\u201310","key":"1742_CR15","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s10495-024-01956-3","volume":"29","author":"X Li","year":"2024","unstructured":"Li X, Guan W, Liu H, Yuan J, Wang F, Guan B, et al. Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse Paclitaxel resistance in ovarian cancer. Apoptosis. 2024;29(9\u201310):1546\u201363. https:\/\/doi.org\/10.1007\/s10495-024-01956-3.","journal-title":"Apoptosis"},{"key":"1742_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124392","author":"J Hrab\u011bta","year":"2020","unstructured":"Hrab\u011bta J, Belhajov\u00e1 M, \u0160ubrtov\u00e1 H, Merlos Rodrigo MA, Heger Z, Eckschlager T. Drug sequestration in lysosomes as one of the mechanisms of chemoresistance of cancer cells and the possibilities of its inhibition. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21124392.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1742_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/0113895575287242240129120002","volume":"24","author":"E Shirbhate","year":"2024","unstructured":"Shirbhate E, Singh V, Mishra A, Jahoriya V, Veerasamy R, Tiwari AK, et al. Targeting lysosomes: a strategy against chemoresistance in cancer. Mini Rev Med Chem. 2024;24(15):1449\u201368. https:\/\/doi.org\/10.2174\/0113895575287242240129120002.","journal-title":"Mini Rev Med Chem"},{"key":"1742_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020115","author":"B Kim","year":"2024","unstructured":"Kim B, Kim G, Kim H, Song YS, Jung J. Modulation of cisplatin sensitivity through TRPML1-mediated lysosomal exocytosis in ovarian cancer cells: a comprehensive metabolomic approach. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13020115.","journal-title":"Cells"},{"issue":"2","key":"1742_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/bj2720407","volume":"272","author":"H Tapper","year":"1990","unstructured":"Tapper H, Sundler R. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem J. 1990;272(2):407\u201314. https:\/\/doi.org\/10.1042\/bj2720407.","journal-title":"Biochem J"},{"issue":"6","key":"1742_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.157","volume":"3","author":"C Cerda-Troncoso","year":"2024","unstructured":"Cerda-Troncoso C, Gr\u00fcnenwald F, Arias-Mu\u00f1oz E, Cavieres VA, Caceres-Verschae A, Hern\u00e1ndez S, et al. Chemo-small extracellular vesicles released in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function. J Extracell Biol. 2024;3(6):e157. https:\/\/doi.org\/10.1002\/jex2.157.","journal-title":"J Extracell Biol"},{"key":"1742_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/membranes10120406","author":"B Tancini","year":"2020","unstructured":"Tancini B, Buratta S, Delo F, Sagini K, Chiaradia E, Pellegrino RM, et al. Lysosomal exocytosis: the extracellular role of an intracellular organelle. Membranes. 2020. https:\/\/doi.org\/10.3390\/membranes10120406.","journal-title":"Membranes"},{"key":"1742_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081096","author":"F Guerra","year":"2019","unstructured":"Guerra F, Bucci C. Role of the RAB7 protein in tumor progression and cisplatin chemoresistance. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11081096.","journal-title":"Cancers"},{"key":"1742_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells14110765","author":"A Ferraresi","year":"2025","unstructured":"Ferraresi A, Ghezzi I, Salwa A, Lualdi C, Dhanasekaran DN, Isidoro C. P53-induced autophagy degradation of NKX3-2 improves ovarian cancer prognosis. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14110765.","journal-title":"Cells"},{"issue":"28","key":"1742_CR24","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41388-018-0189-0","volume":"37","author":"KDP Dorayappan","year":"2018","unstructured":"Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, Cohn DE, Selvendiran K. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins. Oncogene. 2018;37(28):3806\u201321. https:\/\/doi.org\/10.1038\/s41388-018-0189-0.","journal-title":"Oncogene"},{"issue":"9","key":"1742_CR25","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1002\/jcb.27063","volume":"119","author":"I Hussain","year":"2018","unstructured":"Hussain I, Waheed S, Ahmad KA, Pirog JE, Syed V. Scutellaria baicalensis targets the hypoxia-inducible factor-1\u03b1 and enhances cisplatin efficacy in ovarian cancer. J Cell Biochem. 2018;119(9):7515\u201324. https:\/\/doi.org\/10.1002\/jcb.27063.","journal-title":"J Cell Biochem"},{"key":"1742_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.785111","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Du Z-W, Xu T-M, Wang X-J, Li W, Gao J-L, et al. HIF-1\u03b1 is a rational target for future ovarian cancer therapies. Front Oncol. 2021;11:785111. https:\/\/doi.org\/10.3389\/fonc.2021.785111.","journal-title":"Front Oncol"},{"issue":"4","key":"1742_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbamcr.2008.07.014","volume":"1793","author":"E-L Eskelinen","year":"2009","unstructured":"Eskelinen E-L, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta. 2009;1793(4):664\u201373. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.07.014.","journal-title":"Biochim Biophys Acta"},{"key":"1742_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109415","volume":"119","author":"X Li","year":"2019","unstructured":"Li X, Zhou Y, Li Y, Yang L, Ma Y, Peng X, et al. Autophagy: a novel mechanism of chemoresistance in cancers. Biomed Pharmacother. 2019;119:109415. https:\/\/doi.org\/10.1016\/j.biopha.2019.109415.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1742_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188525","volume":"1875","author":"C Tam","year":"2021","unstructured":"Tam C, Rao S, Waye MMY, Ng TB, Wang CC. Autophagy signals orchestrate chemoresistance of gynecological cancers. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188525. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188525.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1742_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061369","author":"MS Chesnokov","year":"2021","unstructured":"Chesnokov MS, Khan I, Park Y, Ezell J, Mehta G, Yousif A, et al. The MEK1\/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13061369.","journal-title":"Cancers"},{"key":"1742_CR31","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2023.152","volume":"7","author":"S Alam","year":"2024","unstructured":"Alam S, Giri PK. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors. Cancer Drug Resistance (Alhambra, Calif). 2024;7:6. https:\/\/doi.org\/10.20517\/cdr.2023.152.","journal-title":"Cancer Drug Resistance (Alhambra, Calif.)"},{"key":"1742_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070907","author":"T Motohara","year":"2019","unstructured":"Motohara T, Katabuchi H. Ovarian cancer stemness: biological and clinical implications for metastasis and chemotherapy resistance. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11070907.","journal-title":"Cancers"},{"issue":"4","key":"1742_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.20517\/cdr.2020.93","volume":"3","author":"A Takahashi","year":"2020","unstructured":"Takahashi A, Hong L, Chefetz I. How to win the ovarian cancer stem cell battle: destroying the roots. Cancer Drug Resist (Alhambra Calif). 2020;3(4):1021\u201333. https:\/\/doi.org\/10.20517\/cdr.2020.93.","journal-title":"Cancer Drug Resist (Alhambra Calif)"},{"issue":"5","key":"1742_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/0109298673276871231205043417","volume":"32","author":"S Zaib","year":"2025","unstructured":"Zaib S, Javed H, Rana N, Zaib Z, Iqbal S, Khan I. Therapeutic chemoresistance in ovarian cancer: emerging hallmarks, signaling mechanisms and alternative pathways. Curr Med Chem. 2025;32(5):923\u201338. https:\/\/doi.org\/10.2174\/0109298673276871231205043417.","journal-title":"Curr Med Chem"},{"issue":"24","key":"1742_CR35","doi-asserted-by":"publisher","first-page":"10769","DOI":"10.1021\/jacs.0c02134","volume":"142","author":"F-F Shen","year":"2020","unstructured":"Shen F-F, Dai S-Y, Wong N-K, Deng S, Wong AS-T, Yang D. Mediating K+\/H\u2009+\u2009transport on organelle membranes to selectively eradicate cancer stem cells with a small molecule. J Am Chem Soc. 2020;142(24):10769\u201379. https:\/\/doi.org\/10.1021\/jacs.0c02134.","journal-title":"J Am Chem Soc"},{"issue":"5","key":"1742_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216553","volume":"14","author":"L Che","year":"2019","unstructured":"Che L, Yang X, Ge C, El-Amouri SS, Wang Q-E, Pan D, et al. Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis. PLoS One. 2019;14(5):e0216553. https:\/\/doi.org\/10.1371\/journal.pone.0216553.","journal-title":"PLoS One"},{"issue":"9","key":"1742_CR37","first-page":"9950","volume":"13","author":"C Nantasupha","year":"2021","unstructured":"Nantasupha C, Thonusin C, Charoenkwan K, Chattipakorn S, Chattipakorn N. Metabolic reprogramming in epithelial ovarian cancer. Am J Transl Res. 2021;13(9):9950\u201373.","journal-title":"Am J Transl Res"},{"key":"1742_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/505041","volume":"2014","author":"G Shuvayeva","year":"2014","unstructured":"Shuvayeva G, Bobak Y, Igumentseva N, Titone R, Morani F, Stasyk O, et al. Single amino acid arginine deprivation triggers prosurvival autophagic response in ovarian carcinoma SKOV3. BioMed Res Int. 2014a;2014:505041. https:\/\/doi.org\/10.1155\/2014\/505041.","journal-title":"BioMed Res Int"},{"issue":"2","key":"1742_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/b:clin.0000024740.44602.b7","volume":"21","author":"G Leto","year":"2004","unstructured":"Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis. 2004;21(2):91\u2013106. https:\/\/doi.org\/10.1023\/b:clin.0000024740.44602.b7.","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"1742_CR40","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1582-4934.2008.00435.x","volume":"13","author":"R Castino","year":"2009","unstructured":"Castino R, Peracchio C, Salini A, Nicotra G, Trincheri NF, D\u00e9moz M, Valente G, Isidoro C. Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop. J Cell Mol Med. 2009a;13(6):1096\u2013109. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00435.x.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1742_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3727\/096504017X14928634401204","volume":"26","author":"C Ji","year":"2018","unstructured":"Ji C, Zhao Y, Kou Y-W, Shao H, Guo L, Bao C-H, Jiang B-C, Chen X-Y, Dai J-W, Tong Y-X, Yang R, Sun W, Wang Q. Cathepsin F knockdown induces proliferation and inhibits apoptosis in gastric cancer cells. Oncol Res. 2018;26(1):83\u201393. https:\/\/doi.org\/10.3727\/096504017X14928634401204.","journal-title":"Oncol Res"},{"issue":"1","key":"1742_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.febslet.2005.12.005","volume":"580","author":"J Liu","year":"2006","unstructured":"Liu J, Guo Q, Chen B, Yu Y, Lu H, Li Y-Y. Cathepsin B and its interacting proteins, Bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90. FEBS Lett. 2006;580(1):245\u201350. https:\/\/doi.org\/10.1016\/j.febslet.2005.12.005.","journal-title":"FEBS Lett"},{"key":"1742_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020448","author":"CM Pfeffer","year":"2018","unstructured":"Pfeffer CM, Singh ATK. Apoptosis: a target for anticancer therapy. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19020448.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1742_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04581-7","volume":"13","author":"SU Seo","year":"2022","unstructured":"Seo SU, Woo SM, Im S-S, Jang Y, Han E, Kim SH, et al. Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells. Cell Death Dis. 2022;13(2):115. https:\/\/doi.org\/10.1038\/s41419-022-04581-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1742_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RSY Wong","year":"2011","unstructured":"Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30(1):87. https:\/\/doi.org\/10.1186\/1756-9966-30-87.","journal-title":"J Exp Clin Cancer Res"},{"issue":"29","key":"1742_CR46","doi-asserted-by":"publisher","first-page":"45995","DOI":"10.18632\/oncotarget.10276","volume":"7","author":"H Sui","year":"2016","unstructured":"Sui H, Shi C, Yan Z, Wu M. Overexpression of cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer. Oncotarget. 2016;7(29):45995\u20136001. https:\/\/doi.org\/10.18632\/oncotarget.10276.","journal-title":"Oncotarget"},{"issue":"6","key":"1742_CR47","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.3892\/ol.2016.4494","volume":"11","author":"H Zhang","year":"2016","unstructured":"Zhang H, Zhang L, Wei L, Gao X, Tang LI, Gong W, Min NA, Zhang LI, Yuan Y. Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapy. Oncol Lett. 2016;11(6):4235\u20139. https:\/\/doi.org\/10.3892\/ol.2016.4494.","journal-title":"Oncol Lett"},{"issue":"9","key":"1742_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41388-025-03291-6","volume":"44","author":"GS Wu","year":"2025","unstructured":"Wu GS, Saftig P, Peters C, El-Deiry WS. Correction: potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene. 2025;44(9):630\u20131. https:\/\/doi.org\/10.1038\/s41388-025-03291-6.","journal-title":"Oncogene"},{"issue":"11","key":"1742_CR49","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","volume":"26","author":"I Chefetz","year":"2019","unstructured":"Chefetz I, Grimley E, Yang K, Hong L, Vinogradova EV, Suciu R, et al. A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells. Cell Rep. 2019;26(11):3061-3075.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.032.","journal-title":"Cell Rep"},{"key":"1742_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-0716-1162-3_11","volume":"2255","author":"M Chesnokov","year":"2021","unstructured":"Chesnokov M, Khan I, Chefetz I. Induction and detection of necroptotic cell death in mammalian cell culture. Methods Mol Biology (Clifton N J). 2021;2255:119\u201334. https:\/\/doi.org\/10.1007\/978-1-0716-1162-3_11.","journal-title":"Methods Mol Biology (Clifton N J)"},{"key":"1742_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107717","volume":"220","author":"I Khan","year":"2021","unstructured":"Khan I, Yousif A, Chesnokov M, Hong L, Chefetz Ii. A decade of cell death studies: breathing new life into necroptosis. Pharmacol Ther. 2021;220:107717. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107717.","journal-title":"Pharmacol Ther"},{"key":"1742_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/bs.apcsb.2022.11.004","volume":"134","author":"T Onal","year":"2023","unstructured":"Onal T, Ozgul-Onal M, Chefetz I. Mixed lineage kinase domain-like pseudokinase: conventional (necroptosis) and unconventional (necroptosis-independent) functions and features. Adv Protein Chem Struct Biol. 2023;134:225\u201343. https:\/\/doi.org\/10.1016\/bs.apcsb.2022.11.004.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"1742_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15(1):199. https:\/\/doi.org\/10.1186\/s12974-018-1235-0.","journal-title":"J Neuroinflammation"},{"key":"1742_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244108","author":"X Ding","year":"2022","unstructured":"Ding X, Zhang C, Chen H, Ren M, Liu X. Cathepsins trigger cell death and regulate radioresistance in glioblastoma. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244108.","journal-title":"Cells"},{"issue":"1","key":"1742_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41418-023-01237-7","volume":"31","author":"S Liu","year":"2024","unstructured":"Liu S, Perez P, Sun X, Chen K, Fatirkhorani R, Mammadova J, Wang Z. MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis. Cell Death Differ. 2024;31(1):40\u201352. https:\/\/doi.org\/10.1038\/s41418-023-01237-7.","journal-title":"Cell Death Differ"},{"key":"1742_CR56","doi-asserted-by":"publisher","unstructured":"Huang Y, Feng Y, Cui L, Yang L, Zhang Q, Zhang J, Jiang X, Zhang X, Lv Y, Jia J-Z, Zhang D-X, Huang Y-S. (2021). Autophagy-Related LC3 Accumulation Interacted Directly With LIR Containing RIPK1 and RIPK3, Stimulating Necroptosis in Hypoxic Cardiomyocytes. Front Cell Dev Biol 2021;9, 679637. https:\/\/doi.org\/10.3389\/fcell.2021.679637","DOI":"10.3389\/fcell.2021.679637"},{"key":"1742_CR57","doi-asserted-by":"crossref","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: Regulator of cell death. Cell Death & Disease. 2023;14(10), 648. https:\/\/doi.org\/10.1038\/s41419-023-06154-8.","DOI":"10.1038\/s41419-023-06154-8"},{"key":"1742_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cells7080094","author":"A du Toit","year":"2018","unstructured":"du Toit A, De Wet S, Hofmeyr J-HS, M\u00fcller-Nedebock KK, Loos B. The precision control of autophagic flux and vesicle dynamics-a micropattern approach. Cells. 2018. https:\/\/doi.org\/10.3390\/cells7080094.","journal-title":"Cells"},{"issue":"32","key":"1742_CR59","doi-asserted-by":"publisher","first-page":"50818","DOI":"10.18632\/oncotarget.10640","volume":"7","author":"ML Goodall","year":"2016","unstructured":"Goodall ML, Cramer SD, Thorburn A. Autophagy complexes cell death by necroptosis. Oncotarget. 2016;7(32):50818\u20139. https:\/\/doi.org\/10.18632\/oncotarget.10640.","journal-title":"Oncotarget"},{"key":"1742_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/bs.ircmb.2019.12.004","volume":"352","author":"DR Miller","year":"2020","unstructured":"Miller DR, Cramer SD, Thorburn A. The interplay of autophagy and non-apoptotic cell death pathways. Int Rev Cell Mol Biol. 2020;352:159\u201387. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.12.004.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"7\u20139","key":"1742_CR61","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2022.0110","volume":"38","author":"L Zhang","year":"2023","unstructured":"Zhang L, Cui T, Wang X. The interplay between autophagy and regulated necrosis. Antioxid Redox Signal. 2023;38(7\u20139):550\u201380. https:\/\/doi.org\/10.1089\/ars.2022.0110.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"1742_CR62","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee J-Y, Oh M, Lee E-W. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med. 2023;55(8):1620\u201331. https:\/\/doi.org\/10.1038\/s12276-023-01077-y.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1742_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-2797(89)90087-2","volume":"71","author":"G Minotti","year":"1989","unstructured":"Minotti G, Aust SD. The role of iron in oxygen radical mediated lipid peroxidation. Chem Biol Interact. 1989;71(1):1\u201319. https:\/\/doi.org\/10.1016\/0009-2797(89)90087-2.","journal-title":"Chem Biol Interact"},{"key":"1742_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216728","volume":"587","author":"J Feng","year":"2024","unstructured":"Feng J, Wang Z-X, Bin J-L, Chen Y-X, Ma J, Deng J-H, et al. Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer. Cancer Lett. 2024;587:216728. https:\/\/doi.org\/10.1016\/j.canlet.2024.216728.","journal-title":"Cancer Lett"},{"key":"1742_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1417750","volume":"12","author":"J Xu","year":"2024","unstructured":"Xu J, Zheng B, Wang W, Zhou S. Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies. Front Cell Dev Biol. 2024;12:1417750. https:\/\/doi.org\/10.3389\/fcell.2024.1417750.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"1742_CR66","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/jog.14779","volume":"47","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Bao L, Li M, Chang K, Yi X. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. J Obstet Gynaecol Res. 2021;47(7):2481\u201391. https:\/\/doi.org\/10.1111\/jog.14779.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"1742_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41416-019-0660-x","volume":"122","author":"N Liu","year":"2020","unstructured":"Liu N, Lin X, Huang C. Activation of the reverse transsulfuration pathway through NRF2\/CBS confers erastin-induced ferroptosis resistance. Br J Cancer. 2020;122(2):279\u201392. https:\/\/doi.org\/10.1038\/s41416-019-0660-x.","journal-title":"Br J Cancer"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01742-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01742-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01742-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:55:00Z","timestamp":1770306900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01742-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01742-1","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not Applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}